<DOC>
	<DOCNO>NCT02243748</DOCNO>
	<brief_summary>This clinical trial study palliative care intervention improve symptom control quality life patient stage II-IV non-small cell lung cancer family caregiver . Palliative care program provide patient caregiver information manage symptom , maintain health well-being , access supportive care service . An interdisciplinary palliative care model may effectively link lung cancer patient appropriate supportive care service timely fashion .</brief_summary>
	<brief_title>Palliative Care Intervention Improving Symptom Control Quality Life Patients With Stage II-IV Non-small Cell Lung Cancer Their Family Caregivers</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Adapt Palliative Care Intervention ( PCI ) test National Cancer Institute ( NCI ) fund Program Project ( P01 ) dissemination oncology setting . II . Determine impact PCI patient outcome include symptom control , quality life ( QOL ) , distress compare usual care group . III . Determine impact PCI family caregiver ( FCG ) outcomes include caregiver burden , caregiver distress , skills preparation QOL compare usual care group . IV . Test effect PCI patient resource utilization compare usual care group . OUTLINE : Participants enrol sequentially 1 2 phase . PHASE I : Participants receive usual care . This phase aid identify usual care pattern site provide audit system utilization well finalization educational material Phase II . PHASE II : Participants receive individualize palliative care comprise tailor educational session design patient FCG modify base pattern observe Phase I . The first patient teach session cover physical psychological area second cover social spiritual area . These session complete within 2 week accrual . A third teaching session hold FCG alone give FCG opportunity discus perspective focus need . Patients ask identify topic want include omitted provide tailor content patient 's need preference . In group , participant follow 3 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patient eligibility criterion entry project include : Diagnosis stage IIIV nonsmall cell lung cancer ( NSCLC ) Undergoing treatment surgery , chemotherapy , radiation , combine modality In Phase 2 , subject also require accrual refer Palliative Care FCG eligibility criterion include : Designated patient person closely involve care Age 18 year old All subject must ability understand willingness sign write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>